In Australia, more than 200,000 people are living with chronic hepatitis B and many are unaware they have the virus. With only one in four people living with chronic hepatitis B receiving regular care, urgent national action is needed to meet Australia’s 2030 hepatitis B elimination targets.
The treatment landscape for hepatitis B is likely to change over the next several years, with the prospect of therapies that provide functional cure.
Existing antiviral therapy remains under-utilised and out of the small numbers of diagnosed people living with hepatitis B, many have not been linked to clinical care. A further area of consideration and hepatitis B strategy development is suitability of current criteria for PBS-provided treatment, with most diagnosed people not eligible.
This World Hepatitis Day, join us for a seminar that will cover epidemiological, clinical care, government, strategic, and community aspects of chronic hepatitis B in Australia, focused on enhancing progress towards Australia's goal of elimination of hepatitis B by 2030.
Speakers to be announced
Opinions expressed by individuals at this event are solely of those of the individual/s and do not necessarily represent the views or opinions of the Kirby Institute or UNSW.